secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cullinan Therapeutics, Inc. (CGEM)
CIK:        0001789972
Form:       8-K
Filed at:   2025-06-12T23:59:59+00:00
Accession:  0000950170-25-085425
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Cullinan Therapeutics annual meeting results: all proposals pass, directors elected
--------------------------------------------------------------------------------

- Elected Class II directors: Anthony Rosenberg, David P. Ryan, Mary Thistle; each received >47M votes for.
- Ratified KPMG as independent auditor for FY2025: 51.9M for, 157K against, 14K abstain.
- Approved advisory say-on-pay on executive compensation: 46.96M for, 2.00M against, 14.7K abstain.
- Stockholders voted for annual say-on-pay frequency (48.5M for 1 year); board adopts annual vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1789972/000095017025085425/0000950170-25-085425-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1789972/000095017025085425/cgem-20250612.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-085425

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer